학술논문

Rationale and Design of a Phase II Trial of Combined Serplulimab and Chemotherapy in Patients with Histologically Transformed Small Cell Lung Cancer: a Prospective, Single-arm and Multicentre Study
Document Type
Article
Source
In Clinical Oncology January 2024 36(1):39-45
Subject
Language
ISSN
0936-6555